Literature DB >> 10865297

Benefit of prophylactic mastectomy for women with BRCA1 or BRCA2 mutations

.   

Abstract

Entities:  

Year:  2000        PMID： 10865297

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy.

Authors:  Min Yi; Kelly K Hunt; Banu K Arun; Isabelle Bedrosian; Angelica Gutierrez Barrera; Kim-Anh Do; Henry M Kuerer; Gildy V Babiera; Elizabeth A Mittendorf; Kaylene Ready; Jennifer Litton; Funda Meric-Bernstam
Journal:  Cancer Prev Res (Phila)       Date:  2010-07-20

2.  Supporting disclosure of genetic information to family members: professional practice and timelines in cancer genetics.

Authors:  Benjamin Derbez; Antoine de Pauw; Dominique Stoppa-Lyonnet; Sandrine de Montgolfier
Journal:  Fam Cancer       Date:  2017-07       Impact factor: 2.375

Review 3.  How Far Do We Go With Genetic Evaluation? Gene, Panel, and Tumor Testing.

Authors:  Filipa Lynce; Claudine Isaacs
Journal:  Am Soc Clin Oncol Educ Book       Date:  2016

4.  Concurrent Prophylactic Mastectomy, Immediate Reconstruction, and Salpingo-Oophorectomy in High-Risk Patients: A Case Series.

Authors:  Josephine A D'Abbondanza; Ralph George; Sari Kives; Melinda A Musgrave
Journal:  Plast Surg (Oakv)       Date:  2020-06-04       Impact factor: 0.947

5.  Cost of contralateral prophylactic mastectomy.

Authors:  Ashish A Deshmukh; Scott B Cantor; Melissa A Crosby; Wenli Dong; Yu Shen; Isabelle Bedrosian; Susan K Peterson; Patricia A Parker; Abenaa M Brewster
Journal:  Ann Surg Oncol       Date:  2014-05-09       Impact factor: 5.344
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.